IN-30101
N/A
Report date: 2023/03/05 19:47:15
NME
Base Information
Drug NameIN-30101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInxmed(Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesInxmed(Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A